Mehr lesen
Fatty liver disease including nonalcoholic steatohepatitis (NASH) involves the ac- mulation of triglycerides in hepatocytes with necrosis,in?ammation,and often ?b- sis with progression to cirrhosis. The two-hit model summarizes the important early metabolic events leading to hepatocellular necrosis in NASH. In these proceedings, we present various new ?ndings and a review of NASH. The liver has an important role in nutritional homeostasis, and liver diseases lead to abnormalities in nutrient metabolism and to subsequent malnutrition,especially in patients with liver cirr- sis. Protein-energy malnutrition (PEM) is a common ?nding in cirrhotic patients; it may be present in 20% of patients with well-compensated disease and in more than 60% of patients with severe liver insuf?ciency. Therefore,special attention is required in the management of those patients; proper nutritional assessment and support for cirrhotic patients is essential. This volume also includes new ?ndings on the nut- tional aspects of the treatment of liver cirrhosis, which we hope will contribute to a better understanding of NASH and nutritional treatment. We thank Otsuka Pharmaceutical Co. Ltd. for their continuing support. Organizing Committee of the Yamaguchi Symposium on Liver Disease Kiwamu Okita,M. D. ,Yamaguchi University,Ube Masamichi Kojiro,M. D. ,Kurume University,Kurume Masao Omata,M. D. ,The University of Tokyo,Tokyo Norio Hayashi,M. D. ,Osaka University,Osaka Takeshi Okanoue,M. D. ,Kyoto Prefectural University of Medicine,Kyoto Secretary General Isao Sakaida,M. D. ,Yamaguchi University,Ube V Table of Contents Preface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V List of Participants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . IX Nonalcoholic Fatty Liver (NAFL): Overview S. H. Caldwell,A. Al-Osaimi,C. Chang,C. Davis,E. E.
Inhaltsverzeichnis
Nonalcoholic Fatty Liver (NAFL): Overview.- Role of Leptin in Pathogenesis of NASH.- Zone 3 Predominance of Histopathological Features in Nonalcoholic Steatohepatitis.- Genetic Background of Japanese Patients with Nonalcoholic Steatohepatitis (NASH).- Predictors of Nonalcoholic Steatohepatitis in Japanese Patients: Thioredoxin and NASH.- Clinical Features of Patients with Nonalcoholic Fatty Liver Disease.- Pathogenesis and Significance of Restricted Diet and Exercise Therapy in Nonalcoholic Steatohepatitis (NASH).- Mammalian Target of Rapamycin (mTOR).- Effect of Oral Supplementation with Branched-Chain Amino Acids on Albumin Concentration in the Early Stage of Cirrhosis.- Nutritional Therapy in Patients with Liver Cirrhosis.
